Deborah Waterhouse
Two months after taking over the role of CEO at ViiV Healthcare, Deborah Waterhouse found herself involved in what would soon become a significant business milestone in the 10-year old company’s history. It was June 2017 when Waterhouse and other executives from ViiV and GSK decided to redeem an FDA priority review voucher for Juluca Read More
